IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common γ-chain of the IL-2 receptor

Journal of Immunology

Volumn 164, Issue 3, 2000, Pages 1175-1184

  Grundström, Susanna ^a   Dohlsten, Mikael ^b   Sundstedt, Anette ^b  

^a Active Biotech Research AB   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ANIMAL CELL; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; DNA BINDING; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HELPER CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0034142187     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.3.1175     Document Type: Article

References (67)

1. King, L. B., and J. D. Ashwell. 1994. Thymocyte and T cell apoptosis: is all death created equal? Thymus 23:209.
2. Miller, J. F., and W. R. Heath. 1993. Self-ignorance in the peripheral T-cell pool. Immunol. Rev. 133:131.
3. Goodnow, C. C. 1997. Glimpses into the balance between immunity and self-tolerance. Ciba Found. Symp. 204:190.
4. Miethke, T., C. Wahl, H. Gaus, K. Hceg, and H. Wagner. 1994. Exogenous superantigens acutely trigger distinct levels of peripheral T cell tolerance/immunosuppression: dose-response relationship. Eur. J. Immunol. 24:1893.
5. Arnon, R., and D. Teitelbaum. 1993. On the existence of suppressor cells. Int. Arch. Allergy Immunol. 100:2.
6. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
7. Beverly, B., S. M. Kang, M. J. Lenardo, and R. H. Schwartz. 1992. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4:661.
8. Kang, S. M., B. Beverly, A. C. Tran, K. Brorson, R. H. Schwartz, and M. J. Lenardo. 1992. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 257:1134.
9. + T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells. Nature 339:541.
10. + T cells by staphylococcal enterotoxin B. J. Exp. Med. 172:1091.
11. + T cells. J. Immunol. 151:2355.
12. Kearney, E. R., K. A. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
13. Rocha, M., A. Kruger, N. Van Rooijen, V. Schirrmacher, and V. Umansky. 1995. Liver endothelial cells participate in T-cell-dependent host resistance to lymphoma metastasis by production of nitric oxide in vivo. Int. J. Cancer 63:405.
14. + T cells persist in vivo following induction of peripheral tolerance. J. Immunol. 160:4719.
15. Baschieri, S., R. K. Lees, A. R. Lussow, and H. R. MacDonald. 1993. Clonal anergy to staphylococcal enterotoxin B in vivo: selective effects on T cell subsets and lymphokines. Eur. J. Immunol. 23:2661.
16. Sundstedt, A., I. Hoiden, A. Rosendahl, T. Kalland, N. Van Rooijen, and M. Dohlsten. 1997. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J. Immunol. 158:180.
17. Sundstedt, A., M. Dohlsten, G. Hedlund, I. Hoiden, M. Bjorklund, and T. Kalland. 1994. Superantigens anergize cytokine production but not cytotoxicity in vivo. [Published erratum appears in 1994, Immunology 82:504.] Immunology 82:117.
18. + T cells. J. Immunol. 154:6306.
19. Takeshita, T., H. Asao, K. Ohtani, N. Ishii, S. Kumaki, N. Tanaka, H. Munakata, M. Nakamura, and K. Sugamura. 1992. Cloning of the γ chain of the human IL-2 receptor. Science 257:379.
20. Meyer, W. K., P. Reichenbach, U. Schindler, E. Soldaini, and M. Nabholz. 1997. Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor a gene transcription. J. Biol. Chem. 272:31821.
21. + T cells of human IL-2 receptor β-chain transgenic mice. J. Immunol. 153:5373.
22. Karnitz, L. M., and R. T. Abraham. 1995. Cytokine receptor signaling mechanisms. Curr. Opin. Immunol. 7:320.
23. Schindler, C., and J. E. J. Darnell. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621.
24. Lin, J. X., T. S. Migone, M. Tsang, M. Friedmann, J. A. Weatherbee, L. Zhou, A. Yamauchi, E. T. Bloom, J. Mietz, and S. John. 1995. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331.
25. Frasca, L., P. Carmichael, R. Lechler, and G. Lombardi. 1997. Anergic T cells effect linked suppression. Eur. J. Immunol. 27:3191.
26. Berg, L. J., A. M. Pullen, D. S. Fazekas, D. Mathis, C. Benoist, and M. M. Davis, 1989. Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell 58:1035.
27. Hedlund, G., M. Dohlsten, T. Herrmann, G. Buell, P. A. Lando, S. Segren, J. Schrimsher, H. R. MacDonald, H. O. Sjogren, and T. Kalland. 1991. A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J. Immunol. 147:4082.
28. Mott, H. R., B. S. Baines, R. M. Hall, R. M. Cooke, P. C. Driscoll, M. P. Weir, and I. D. Campbell. 1995. The solution structure of the F42A mutant of human interleukin 2. J. Mol. Biol. 247:979.
29. De Jong, J. L., N. L. Farner, M. B. Widmer, J. G. Giri, and P. M. Sondel. 1996. Interaction of IL-15 with the shared IL-2 receptor β and γ c subunits: the IL-15/β/γ c receptor-ligand complex is less stable than the IL-2/β/γ c receptor-ligand complex. J. Immunol. 156:1339.
30. Sogaard, M., L. Ohlsson, K. Kristensson, A. Rosendahl, A. Sjöberg, G. Forsberg. T. Kalland, and M. Dohlsten. 1999. Treatment with tumor-reactive Fab-IL-2 and Fab-staphylococcal enterotoxin A fusion proteins leads to sustained T cell activation, and long-term survival of mice with established tumors. Int. J. Oncol. 15:873.
31. Dohlsten, M., M. Bjorklund, A. Sundstedt, G. Hedlund, D. Samson, and T. Kalland. 1993. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor Vβ3 transgenic mice. Immunology 79:520.
32. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:2822.
33. Nakajima, H., X. W. Liu, A. Wynshaw-Boris, L. A. Rosenthal, K. Imada, D. S. Finbloom, L. Hennighausen, and W. J. Leonard. 1997. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction. Immunity 7:691.
34. Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
35. Johnston, J. A., C. M. Bacon, D. S. Finbloom, R. C. Rees, D. Kaplan, K. Shibuya, J. R. Ortaldo, S. Gupta, Y. Q. Chen, and J. D. Giri. 1995. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acad. Sci. USA 92:8705.
36. c chain of the IL-2 receptor. Science 266:1039.
37. Miyazaki, T., A. Kawahara, H. Fujii, Y. Nakagawa, Y. Minami, Z. J. Liu, I. Oishi, O. Silvennoinen, B. A. Witthuhn, and J. N. Ihle. 1994. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266:1045.
38. Higuchi, M., H. Asao, N. Tanaka, K. Oda, T. Takeshita, M. Nakamura, J. Van Snick, and K. Sugamura. 1996. Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line. Eur. J. Immunol. 26:1322.
39. Lombardi, G., S. Sidhu, R. Batchelor, and R. Lechler. 1994. Anergic T cells as suppressor cells in vitro. Science 264:1587.
40. Blackman, M. A., T. H. Finkel, J. Kappler, J. Cambier, and P. Marrack. 1991. Altered antigen receptor signaling in anergic T cells from self-tolerant T-cell receptor β-chain transgenic mice. Proc. Natl. Acad. Sci. USA 88:6682.
41. Ferber, I., G. Schonrich, J. Schenkel, A. L. Mellor, G. J. Hammerling, and B. Arnold. 1994. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 263:674.
42. Arnold, B., G. Schonrich, and G. J. Hammerling. 1993. Multiple levels of peripheral tolerance. Immunol. Today 14:12.
43. Taams, L. S., W. van Eden, and M. H. Wauben. 1999. Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy. J. Immunol. 162:1974.
44. Chai, J. G., I. Bartok, P. Chandler, S. Vendetti, A. Antoniou, J. Dyson, and R. Lechler. 1999. Anergic T cells act as suppressor cells in vitro and in vivo. Eur. J. Immunol. 29:686.
45. Taams, L. S., A. J. van Rensen, M. C. Poelen, C. A. van Els, A. C. Besseling, J. P. Wagenaar, W. van Eden, and M. H. Wauben. 1998. Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur. J. Immunol. 28:2902.
46. + T cells J. Exp. Med. 184:19.
47. Dallman, M. J., O. Shiho, T. H. Page, K. J. Wood, and P. J. Morris. 1991. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J. Exp. Med. 173:79.
48. Nelson, B. H., J. D. Lord, and P. D. Greenberg. 1994. Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation. Nature 369:333.
49. Zhang, Q., I. Nowak, E. C. Vonderheid, A. H. Rook, M. E. Kadin, P. C. Nowell, L. M. Shaw, and M. A. Wasik. 1996. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc. Natl. Acad. Sci. USA 93:9148.
50. c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266:1042.
51. Bright, J. J., L. D. Kerr, and S. Sriram. 1997. TGF-β inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes. J. Immunol. 159:175.
52. Kirken, R. A., H. Rui, M. G. Malabarba, O. M. Howard, M. Kawamura, J. J. O'Shea, and W. L. Farrar. 1995. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor β-chain. Cytokine 7:689.
53. Ascherman, D. P., T. S. Migone, M. C. Friedmann, and W. J. Leonard. 1997. Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor a chain gene: critical role of two functionally redundant tyrosine residues in the IL-2 receptor β chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation. J. Biol. Chem. 272:8704.
54. Gaffen, S. L., S. Y. Lai, W. Xu, F. Gouilleux, B. Groner, M. A. Goldsmith, and W. C. Greene. 1995. Signaling through the interleukin 2 receptor β chain activates a STAT-5-like DNA-binding activity. Proc. Natl. Acad. Sci. USA 92:7192.
55. Gaffen, S. L., S. Y. Lai, M. Ha, X. Liu, L. Hennighausen, W. C. Greene, and M. A. Goldsmith. 1996. Distinct tyrosine residues within the interleukin-2 receptor β chain drive signal transduction specificity, redundancy, and diversity. J. Biol. Chem. 271:21381.
56. Zhu, M. H., J. A. Berry, S. M. Russell, and W. J. Leonard. 1998. Delineation of the regions of interleukin-2 (IL-2) receptor β chain important for association of Jak1 and Jak3: Jak1-independent functional recruitment of Jak3 to IL-2Rβ. J. Biol. Chem. 273:10719.
57. Oakes, S. A., F. Candotti, J. A. Johnston, Y. Q. Chen, J. J. Ryan, N. Taylor, X. Liu, L. Hennighausen, L. D. Notarangelo, W. E. Paul, et al. 1996. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity 5:605.
58. Kawahara, A., Y. Minami, T. Miyazaki, J. N. Ihle, and T. Taniguchi. 1995. Critical role of the interleukin 2 (IL-2) receptor γ-chain-associaled Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc. Natl. Acad. Sci. USA 92:8724.
59. Coffer, P., C. Lutticken, A. van Puijenbroek, J. M. Klop-de, F. Horn, and W. Kruijer. 1995. Transcriptional regulation of the junB promoter: analysis of STAT-mediated signal transduction. Oncogene 10:985.
60. Lin, J. X., J. Mietz, W. S. Modi, S. John, and W. J. Leonard. 1996. Cloning of human Stat5B: reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J. Biol. Chem. 271:10738.
61. Moriggl, R., D. J. Topham, S. Teglund, V. Sexl, C. McKay, D. Wang, A. Hoffmeyer, J. van Deursen, M. Y. Sangster, K. D. Bunting, et al. 1999. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10:249.
62. Matsumura, I., T. Kitamura, H. Wakao, H. Tanaka, K. Hashimoto, C. Albanese, J. Downward, R. G. Pestell, and Y. Kanakura. 1999. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18:1367.
63. Gouilleux, F., C. Pallard, I. Dusanter-Fourt, H. Wakao, L. A. Haldosen, G. Norstedt, D. Levy, and B. Groner. 1995. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J. 14:2005.
64. John, S., U. Vinkemeier, E. Soldaini, J. E. J. Darnell, and W. J. Leonard. 1999. The significance of tetramerization in promoter recruitment by Stat5. Mol. Cell. Biol. 19:1910.
65. Verdier, F., R. Rabionet, F. Gouilleux, C. Beisenherz-Huss, P. Varlet, O. Muller, P. Mayeux, C. Lacombe, S. Gisselbrecht, and S. Chretien. 1998. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B. Mol. Cell. Biol. 18:5852.
66. Nicholson, S. E., and D. J. Hilton. 1998. The SOCS proteins: a new family of negative regulators of signal transduction. J. Leukocyte Biol. 63:665.
67. Ito, S., P. Ansari, M. Sakatsume, H. Dickensheets, N. Vazquez, R. P. Donnelly, A. C. Larner, and D. S. Finbloom. 1999. Interleukin-10 inhibits expression of both interferon α- and interferon γ-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 93:1456.